- Filed
- Mar 11, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 6, 2025 | 53.05M sh |
| Long Term Debt | Q1 2025 · Jan 31, 2025 | $417.06M |
| Long Term Debt | Q1 2025 · Oct 31, 2024 | $373.26M |
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $85.13M |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $43.04M |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $93.23M |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $56.33M |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $627.15M |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $551.28M |
| Current Assets | Q1 2025 · Jan 31, 2025 | $140.91M |
| Current Assets | Q1 2025 · Oct 31, 2024 | $112.36M |
| Total Assets | Q1 2025 · Oct 31, 2024 | $897.99M |
| Shares Diluted restated | Q1 2025 · Jan 31, 2024 | 53.32M sh |
| Stock Repurchased | Q1 2025 · Jan 31, 2024 | $1.1M |
| Capex | Q1 2025 · Jan 31, 2024 | $17.77M |
| Operating Cash Flow | Q1 2025 · Jan 31, 2024 | $20.3M |
| Stockholders Equity | Q1 2025 · Jan 31, 2024 | $307.94M |
| Stockholders Equity | Q1 2025 · Oct 31, 2023 | $308.24M |
| Eps Diluted | Q1 2025 · Jan 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Jan 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Jan 31, 2024 | $31.86M |
| Net Income | Q1 2025 · Jan 31, 2024 | −$3.83M |
| Operating Income | Q1 2025 · Jan 31, 2024 | $1.46M |
| Gross Profit | Q1 2025 · Jan 31, 2024 | $33.31M |
| Cost Of Revenue | Q1 2025 · Jan 31, 2024 | $64.4M |
| Revenue | Q1 2025 · Jan 31, 2024 | $89.96M |